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Abstract
The hypolipidemic and hypoglycemic effects of two dietary dosages (0.1% and 0.5%) of water and 80% ethanol extracts from hot-air dried Orostachys
japonicus A. Berger were evaluated in the serum and organ tissues of streptozotocin-induced diabetic rats. The STZ-induced diabetic groups supplemented
with the O. japonicus extracts showed significantly higher body weight compared to a diabetic control group at the end of experiment. The extracts
exhibited substantial hypoglycemic effects by significant reductions of fasting blood glucose levels at all time points tested compared to the initial
stage before treatment of the extracts. Declines of serum and hepatic triglyceride levels were greater than declines of total cholesterol in the groups
treated with the 0.5% O. japonicus extract (DBW2 and DBE2) when compared to the DBC group. Hepatic glycogen content was higher in the
groups treated with O. japonicus extract, while lipid peroxide content was decreased in these treated groups compared to the DBC group. Hepatic 
antioxidant activity was significantly increased in the groups supplemented with the O. japonicus ethanol extract. The hypolipidemic and hypoglycemic
effects of the O. japonicus ethanol extract were significantly greater than the effects of the water extract. Based on this study, it seems that O.
japonicus ethanol extract, due to its higher phenolic and flavonoid components than the water extract, may control blood glucose and alleviate
hyperlipidemia in diabetes. 
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Introduction4)
Diabetes mellitus is a chronic and progressive disorder 
characterized by hyperglycemia and metabolic disturbances of 
carbohydrate, protein, and lipids [1]. In particular, type 2 diabetes 
has increased over recent years in Korea, in accordance with 
age, obesity, and smoking [2]. This is related to hepatic insulin 
resistance, which leads to dyslipidemia and cardiovascular 
disease, such as raised triglyceride and low density lipoprotein 
(LDL) levels, and a reduced high density lipoprotein (HDL) level 
in serum [3]. Cardiovascular disease as a severe chronic comp-
lication is 2-4 times higher in diabetic patients than the healthy 
population [4]. Because modern medicine has side-effects and 
no means by which to completely cure diabetes mellitus [5], 
elderly people in Korea have used traditional herbs as alternative 
therapeutic medicines to prevent cardiovascular disease comp-
lications in diabetes. The potential anti-hyperlipidemic [6,7] and 
antidiabetic effects [8,9] of several traditional plants have been 
reported in Korea. 
Orostachys japonicus (O. japonicus) A. Berger (Crassulaceae), 
commonly called “wa-song” in Korea, is a herbal folk remedy 
for treatment or prevention of chronic diseases including hepatitis, 
hemorrhoids, hematemesis, and cancer [10]. Phytochemicals such 
as triterpense [11,12], phytosterols [12],
  and flavonoids [13-15] 
have been isolated from this plant. We determined the antioxidant 
activities of O. japonicus extract by different drying conditions 
such as sun-drying, hot-air drying, and freeze drying, and found 
that the hot-air dried O. japonicus had the highest antioxidant 
activity due to a higher content of phenolic compounds [16].
 
It was also found to delay antioxidant activities for lipid peroxida-
tion reactions in a lipid emulsion model system [17]. We recently 
reported that quercetin and kaempferol derivatives are major 
flavonoid components of O. japonicus, and these components 
may be important contributors to free radical scavenging, in vitro 
[15]. In particular, quercetin also suppresses glucose levels in diabetic 
rats, and reduces plasma cholesterol and triglycerides probably by 
enhancing insulin release from pancreatic islets in diabetic rats [18,19].
Because there has been no systematic in vivo study of O. 
japonicus, this  research evaluated the hypolipidemic and 
hypoglycemic effects of O. japonicus in relation to the antioxidant 
activity of O. japonicus in vitro, to provide further folkloric uses 
in treating diabetes mellitus [15-17,20]. 
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Ingredients NC* DBC DBW1 DBW2 DBE1 DBE2
Corn starch 39.80 39.80 39.70 39.30 39.70 39.30
Casein 20 20 20 20 20 20
Dextrin 13.2 13.2 13.2 13.2 13.2 13.2
Cellulose 5 5 5 5 5 5




2)  3 . 53 . 53 . 53 . 53 . 53 . 5
DL-methionine 0.3 0.3 0.3 0.3 0.3 0.3
Choline bitartrate  0.2 0.2 0.2 0.2 0.2 0.2
C o r n  o i l 777777
Water extract of 
O. japonicus 
-- 0 . 1 0 . 5 --
Ethanol extract of 
O. japonicus
---- 0 . 1 0 . 5
1,2) Vitamin  mixture  and  mineral  mixture  were  prepared  according  to  AIN-76
TM 
NC, no induced diabetes; DBC, STZ-induced diabetes; DBW1 and DBW2, groups 
with  diabetes  that  received  0.1%  and  0.5%  water  extracts  of  O.  japonicus, 
respectively; DBE1 and DBE2, groups with diabetes that received 0.1% and 0.5% 
ethanol  extracts  of  O.  japonicus,  respectively
Table 1. Composition of diets (%) Materials and Methods 
Plant material
O. japonicus A. Berger was obtained from local medicinal herb 
cultivators in Jinju city, Korea, during July-August, 2006. It was 
authenticated by an herbal doctor from an oriental medicine clinic 
located in Jinju city as well as professor Jin Ho Kang, Research 
Institute of Life Science in Gyeongsang National University. The 
whole tissue of the fresh plant was rinsed with tap water, dried 
by a hot-air dryer (CF-21WF, JEIOTECH, Daejeon, Korea) at 
70℃ for 4-5 h, powdered by 80-100 mesh, and stored at -40℃.
Preparation of plant extracts
The powder of hot-air dried O. japonicus (100 g) was extracted 
in water and 80% ethanol (1 L) at 70℃ for 3 h, respectively. 
The extracts were filtered through filter paper (Whatman No. 
6, Whatman International Ltd., Maidstone, UK) after centrifuging 
(Mega 17R, HANILE, Inchon, Korea) at 3,000 rpm for 10 min. 
The residues were extracted two times. The supernatants were 
concentrated under reduced pressure using a rotary evaporator, 
and lyophilized to give a powder (yields were 2.76% and 0.72% 
in the water and 80% ethanol extract of O. japonicus, respectively). 
They were stored at -40℃ and used for animal treatments.
Experimental animals
Male albino Sprague-Dawley (SD) rats were purchased from 
Samtako Bio Korea Inc. (Osan, Korea). Anti-diabetic studies 
were performed on healthy 5 week-old rats that weighed 150
± 10 g. All rats were kept in automatic chambers (DJ1-252-2, 
Daejong Instrument Industry Co. Ltd., Seoul, Korea) with a room 
temperature of 22 ± 2℃, humidity of 50 ± 5%, and a constant 
light and dark cycle at 12 h (07:00-19:00) each. To help them 
adapt to the laboratory conditions, the rats were fed a standard 
pellet diet (Samtako Bio Korea Inc. Osan, Korea) with water 
ad libitum the first week prior to the experiment. 
Experimental design 
We used STZ (Sigma Co., St. Louis, MO, USA) as a diabetic 
model to maintain a mild and stable form of diabetes during 
the experimental period; this induced diabetic syndrome is partly 
similar to type 2 diabetes in humans [21]. The STZ was freshly 
dissolved in citrate buffer (0.01 M, pH 4.5) and immediately 
injected intraperitoneally with a single dose of 50 mg/kg in 
overnight fasted SD rats. After 48 h of STZ injection, diabetes 
was confirmed by blood samples collected from the tip of the 
tail using a blood glucometer (ACCU-CHEK, Mannheim, Germany). 
The rats with a fasting blood glucose level above 300 mg/dL 
were considered diabetic and were used in the experiment. 
The normal group (NC) served as nondiabetic control rats 
treated with saline instead of STZ and a normal diet. The diabetic 
rats were randomly divided into 5 groups of 7 rats each. Of the 
diabetic groups, DBC as the diabetic control group received only 
a normal diet. The DBW1 and DBW2 groups received diets 
supplemented with 0.1% and 0.5% of O. japonicus water extract, 
respectively. The DBE1 and DBE2 groups received diets 
supplemented with 0.1% and 0.5% of O. japonicus ethanol 
extract, respectively. The extracts were mixed with a normal diet 
(rodent AIN-76 basal diet), and all animals had free access to 
eat. The composition of the diet is shown in Table 1. 
Experimental procedure
Food and water intake were monitored daily at the same time 
during the experimental period. The food efficiency ratio (FER) 
was calculated as the total body weight gain (g)/total food intake 
amount (g) during the experimental period. At the end of the 
experimental period, the rats were sacrificed following an overnight 
fast by an overdose of ethyl ether. Blood samples were collected 
from the heart and the serum was collected by centrifugation 
at 5,000 rpm for 10 min at 4℃. The serum was stored at -70℃ 
prior to analysis. The liver, kidney, and heart were excised 
rapidly, and chilled and rinsed in ice cold 0.9% aqueous sodium 
chloride. They were stored at -70℃ prior to analysis. 
Biochemical analysis of serum 
Changes in fasting blood glucose (FBG) were measured using 
a glucometer with serum obtained from the tail vein every week. 
Serum total cholesterol (TC), triglyceride (TG), and high density 
lipoprotein cholesterol (HDL-C) levels were determined by a 
blood biochemical analyzer (DRI-CHEM 3500i/3500s automated 
clinical chemical analyzer, Fuji, Tokyo, Japan) using appropriate Soo Jung Lee et al. 303
Group  Initial body weight (g) Final body weight (g) Food intake (g/rat/day) Water intake (mL/rat/day) FER
NC 196.00 ± 4.00
NS 286.40 ± 8.80
d 19.60 ± 1.10
a 30.20 ± 3.10
a 0.163 ± 0.006
e
DBC 201.70 ± 7.50 175.00 ± 10.20
a 27.20 ± 2.60
b 196.80 ± 12.90
c -0.037 ± 0.006
a
DBW1 200.00 ± 2.00 195.50 ± 3.30
b 24.20 ± 1.40
ab 170.80 ± 18.70
bc -0.007 ± 0.003
b
DBW2 198.00 ± 4.50 203.40 ± 5.40
b 23.10 ± 1.80
ab 157.60 ± 12.60
b 0.010 ± 0
c
DBE1 199.00 ± 3.50 215.50 ± 4.50
c 23.50 ± 3.50
ab 152.40 ± 21.40
b 0.027 ± 0.006
d
DBE2 202.00 ± 4.50 220.00 ± 5.60
c 20.70 ± 3.10
a 144.50 ± 18.60
b 0.030 ± 0
d
Values  not  sharing  a  common  superscript  letter  differ  from  each  other  significantly  at  P < 0.05.
FER,  Food  efficiency  ratio 
Table 2. Body weight, food and water intake, and FER in STZ-induced diabetic rats supplemented with O. japonicus extracts for 4 weeks
Fig. 1. Changes in fasting blood glucose levels in STZ-induced diabetic rats 
supplemented with O. japonicus extracts during 4 weeks. Different superscripts 
indicate a significant difference (P < 0.05). Significant differences for the DBW2 and 
D B E 1  g r o u p s  s h o w  t h e  s a m e  l e t t e r s . 
kit reagents (TCHO-PⅢ, TG-PⅢ, and HDL-C-PⅢ, Fuji, Tokyo, 
Japan), respectively. Low density lipoprotein cholesterol (LDL-C) 
levels were calculated by Friedewald’s equation: TC－(HDL-C
+ TG/5) [22]. The atherogenic index (AI) was calculated by the 
following equation: (TC-HDL-C)/HDL-C [23]. Cardiovascular 
risk factors (CRF) were calculated by the ratio of HDL-C to 
TC (TC/HDL-C) [24]. GOT (glutamic oxaloacetic transaminase) 
and GPT (glutamic pyruvic transaminase) activities in serum 
were measured using GOT-PⅢ and GPT-PⅢ kit reagents (Fuji), 
respectively.
Lipid analysis in liver, kidney,and heart tissues
Lipid levels of the organ tissues (liver, kidney, and heart) were 
determined according to the method of Folch et al. [25]. Each 
tissue (0.5 g) sample was homogenized with 30 mL of chloroform: 
methanol (2:1, v/v) solution, extracted for 24 h, and filtrated with 
filter paper (Whatman No. 6, Whatman International Ltd.). The 
filtrate was completely dried by a rotary evaporator at 30-40℃, 
and the residue was used to determine TC and TG.
Hepatic protein, glycogen, and lipid peroxide analysis
Protein levels in the rats were determined by the method of 
Lowry et al. [26]. The glycogen contents of the rat livers were 
determined using anthrone reagent (Fluka Chemical Co., Buchs, 
Switzerland) [27]. D-glucose (Sigma Co.) was used as a standard 
for the calibration curve and glycogen content was expressed 
as mg/g of wet tissue. Lipid peroxide levels were determined 
according to the method of Mihara and Uchiyama [28]. 1,1,3,3- 
tetraethoxypropan (Sigma Co.) was used as a standard.
Hepatic antioxidant activity assay 
To analyze hepatic antioxidant activity, liver tissue (1 g) was 
homogenized in 10 mL of cold 1.5% KCl solution to obtain a 
10% (w/v) homogenate. The antioxidant activity was assayed 
according to the method of Lim et al. [29] with slight modifications. 
Each sample (200 µL) was thoroughly mixed with 1 mL of 
Tris-HCl buffer (100 mM, pH 7.4), and 2 mL of 1,1-diphenyl- 
2-picrylhydrazyl (DPPH, Sigma Co., 2.5 mg/100 mL ethanol) 
was added rapidly. The mixture was incubated at 37℃ for 15 
min before it was added to 4 mL of chloroform. After centrifugation 
at 5,000 rpm for 5 min at 4℃, the absorbance of the chloroform 
layer was measured at 517 nm and chloroform was used as a 
blank. The antioxidant activity was expressed as the scavenging 
ratio of DPPH reagent color (%).
Statistical analysis
Values are presented as means ± SD (n = 7). Statistical differences 
among the groups were determined by ANOVA followed by 
Duncan’s multiple range test (P< 0.05) using the SPSS program 
(version 12.0).
Results
Body weight, food intake, water intake, and FER
No significant changes were observed in baseline body weight 
values. There were significant differences in final body weight 




Total cholesterol Triglyceride HDL-C LDL-Cholesterol
NC 94.87 ± 2.42
a 90.78 ± 4.00
a 57.60 ± 1.62
d 19.11 ± 1.64
a 0.50 ± 0.06
a 1.64 ± 0.05
a
DBC 114.46 ± 4.35
c 128.21 ± 3.81
d 33.89 ± 2.50
a 54.93 ± 5.38
d 2.39 ± 0.32
d 3.39 ± 0.32
e
DBW1 104.91 ± 3.50
b 117.65 ± 4.08
c 41.67 ± 2.14
b 39.71 ± 4.00
c 1.39 ± 0.32
c 2.52 ± 0.17
d
DBW2 101.35 ± 1.40
b 107.99 ± 2.55
b 44.40 ± 1.82
b 35.35 ± 1.90
bc 1.22 ± 0.27
bc 2.28 ± 0.10
cd
DBE1 102.51 ± 3.25
b 95.79 ± 2.20
a 51.08 ± 3.11
c 32.27 ± 0.74
b 0.92 ± 0.17
ab 2.01 ± 0.06
bc
DBE2 100.13 ± 3.33
ab 91.57 ± 2.54
a 57.04 ± 2.91
d 24.77 ± 3.67
a 0.70 ± 0.23
a 1.76 ± 0.11
ab
Values  not  sharing  a  common  superscript  letter  differ  from  each  other  significantly  at  P < 0.05.
HDL-C, high  density lipoprotein  cholesterol; LDL-C, low density  lipoprotein  cholesterol;  AI,  Atherogenic  index;  CRF,  Cardiovascular  risk  factor




NC 152.87 ± 2.50
a 31.77 ± 2.10
a
DBC 289.27 ± 1.97
e 111.80 ± 2.14
e
DBW1 267.20 ± 1.64
d 106.46 ± 1.30
d
DBW2 250.73 ± 1.91
b 91.07 ± 1.53
b
DBE1 256.23 ± 2.51
c 94.72 ± 0.77
c
DBE2 251.93 ± 1.18
b 92.97 ± 2.14
bc
Values not sharing a common superscript letter differ from each other significantly 
at  P < 0.05.
GOT,  glutamic  oxaloacetic  transaminase;  GPT,  glutamic  pyruvic  transaminase
Table 4. GOT and GPT activities in serum of STZ-induced diabetic rats 
supplemented with O. japonicus extracts for 4 weeks
to the NC group (Table 2). The fed amounts of O. japonicus 
extract from daily food intake were calculated as 24.2 mg/rat/day 
in the DBW1 and DBE1 groups, 115.5 mg/rat/day in the DBW2 
group, and 103.5 mg/rat/day in the DBE2 group. The STZ- 
induced diabetic groups supplemented with the O. japonicus 
extracts had significantly increased body weight compared to the 
DBC group, although total food intake was not significantly 
different. The FERs of groups treated with the O. japonicus ethanol 
extract were better than those treated with the water extract. 
Effect of O. japonicus extracts on FBG level
The water and ethanol extracts of O. japonicus were administered 
at different doses (0.1% and 0.5%, respectively) in STZ-induced 
diabetic rats for 4 weeks. The effects of the extracts on weekly 
FBG levels are presented in Fig. 1. The FBG level of the NC 
group during the 4 weeks was about 95.5 mg/dL, while FBG 
in the STZ-induced diabetic groups was about 328.8 mg/dL at 
the initial stage before extract administration. The supplementation 
of O. japonicus extract in the STZ-induced diabetic rats produced 
significant suppression of FBG levels at all points tested 
compared to the initial stage. Moreover, at the end of the 4 weeks 
of treatment, better declines in FBG level were observed in the 
DBW2, DBE1, and DBE2 groups compared to the DBW1 group 
(P <0 . 0 5 ) .
Serum lipids profiles 
The levels of serum lipids such as TC, TG, HDL-C, and 
LDL-C, as well as AI and CRF values at the end of the experimental 
period are presented in Table 3. Significant differences in TC, 
TG, HDL-C, and LDL-C were observed between the DBC group 
and groups treated with O. japonicus extract. However, TC levels 
were not significantly different according to the dosage amounts 
of the extract. The TG levels of the DBW2 and DBE2 groups 
declined by 15.8% and 28.6% compared to the DBC group, 
respectively. TG levels in the DBE2 group were recovered to 
normal values. HDL-C levels were significantly decreased in the 
DBC group with respect to the NC group, while there was a 
significant elevation of HDL-C in all groups treated with the 
O. japonicus extracts. This was especially apparent in the DBE2 
group (P< 0.05). AI and CRF values were significantly decreased 
in the groups treated with O. japonicus extract compared to the 
DBC group. 
Serum GOT and GPT activities 
Serum GOT and GPT activities are shown in Table 4. All 
groups treated with the O. japonicus extract had significant 
decreases in GOT and GPT activities compared to the DBC 
group. And these decreased activities occurred in a dose-dependent 
manner. Furthermore, with 0.1% supplementation of the O. 
japonicus extract, the group fed the ethanol extract (DBE1) had 
more significant effects than the group fed the water extract 
(DBW1).
Lipid profiles of liver, kidney, and heart tissues
The lipid profiles of organ tissues are shown in Table 5. Lipid 
levels in the tissues were significantly decreased in the groups 
supplemented with O. japonicus extract compared to the DBC 
group. TG levels in the liver tissue were reduced about 27.4% 
and 45.9% in the DBW2 (12.21 mg/g) and DBE2 (9.10 mg/g) 
groups as compared to the DBC group (16.82 mg/g), respectively. 
In the DBE2 group, TG levels in the kidney and heart tissue 
were decreased to 37.0% and 40.6%, respectively, compared to 
the DBC group.Soo Jung Lee et al. 305
Group
Concentration (mg/g wet tissue)
Liver Kidney Heart
TC TG TC TG TC TG
NC 2.73 ± 0.37
ab 6.45 ± 1.83
a 3.06 ± 0.09
a 8.58 ± 1.32
a 0.90 ± 0.18
a 3.06 ± 0.66
a
DBC 3.27 ± 0.16
b 16.82 ± 1.69
d 3.72 ± 0.10
c 12.93 ± 0.78
c 1.21 ± 0.19
b 4.70 ± 0.98
b
DBW1 2.96 ± 0.16
ab 13.52 ± 1.58
c 3.42 ± 0.10
b 11.56 ± 1.90
bc 0.95 ± 0.05
a 3.59 ± 0.08
a
DBW2 2.87 ± 0.59
ab 12.21 ± 1.54
c 3.27 ± 0.19
ab 9.44 ± 0.81
ab 0.94 ± 0.04
a 3.38 ± 0.11
a
DBE1 2.62 ± 0.32
ab 11.44 ± 1.67
bc 3.31 ± 0.17
ab 9.17 ± 0.99
a 0.85 ± 0.02
a 3.11 ± 0.07
a
DBE2 2.52 ± 0.39
a 9.10 ± 1.53
ab 3.09 ± 0.10
a 8.15 ± 1.40
a 0.84 ± 0.03
a 2.79 ± 0.07
a
Values  not  sharing  a  common  superscript  letter  differ  from  each  other  significantly  at  P < 0.05.
Table 5. Total cholesterol and triglyceride levels in organs (liver, kidney, and heart) of STZ-induced diabetic rats supplemented with O. japonicus extracts for 4 weeks
Group 







NC 9.21 ± 0.79
b 12.25 ± 1.42
c 4.46 ± 0.29
a
DBC 5.49 ± 0.30
a 6.33 ± 0.73
a 14.55 ± 2.36
c
DBW1 6.17 ± 0.15
a 7.97 ± 1.38
ab 9.88 ± 1.49
b
DBW2 6.60 ± 2.10
a 11.24 ± 2.08
bc 7.77 ± 1.78
b
DBE1 7.05 ± 1.45
ab 10.38 ± 1.99
bc 8.02 ± 1.68
b
DBE2 7.48 ± 0.99
ab 11.69 ± 2.44
c 7.41 ± 1.53
b
Values not sharing a common superscript letter differ from each other significantly 
at  P < 0.05.
Table 6. Total protein, glycogen, and lipid peroxide contents in livers of 
STZ-induced diabetic rats supplemented with O. japonicus extracts during for 
4 weeks
Fig. 2. Hepatic antioxidant activity in STZ-induced diabetic rats supplemented 
with O. japonicus extracts for 4 weeks. Different superscripts indicate a significant 
difference  (P < 0.05)  among  the  groups.
Hepatic protein, glycogen, and lipid peroxide contents
As presented in Table 6, the hepatic protein contents of the 
groups supplemented with O. japonicus extract were not 
significantly different from that of the DBC group. The hepatic 
glycogen contents of the DBW2, DBE1, and DBE2 groups were 
significantly higher than that of the DBC group. In particular, 
glycogen content in the DBE2 group was similar to that in the 
NC group. Lipid peroxide content was significantly increased 
in the DBC group with respect to the NC group, but significantly 
lower in the groups treated with O. japonicus extract compared 
to the DBC group. However, there were no significant differences 
among the groups fed the O. japonicus extracts.
Hepatic antioxidant activity 
Hepatic antioxidant activity was tested by the DPPH radical 
scavenging ratio and is shown in Fig. 2. Hepatic antioxidant 
activity was significantly increased in the groups treated with 
the  O. japonicus extracts compared to the DBC group. The 
ethanol extract of O. japonicus was more effective at elevating 
antioxidant activity than the water extract. 
Discussion
Several reviews on the bioactivity of flavonoids from O. 
japonicus and their potential therapeutic uses for diabetic control 
have been published [30-32].
  Total flavonoid content (361.6 
mg/100 g) from O. japonicus, including quercetin derivatives 
(50.80-694.03 mg/kg) and kaempferol derivatives (402.09-408.19 
mg/kg), has been determined by HPLC-MS/MS. Quercetin and 
kaempferol derivatives occupy about 53% of the total flavonoid 
content in O. japonicus [15]. Moreover, polyphenol and flavonoid 
components in the plant were found to be closely connected to 
its antioxidant activities [15-17,20]. However, the relationship 
of dietary flavonoids to type 2 diabetes therapy is less well- 
studied in Korea. Therefore, in this study, we surmised that these 
compounds would be able to cause hypolipidemic and hypoglycemic 
effects in STZ-induced diabetic rats. 
Table 2 reveals the phenomena of polyphagia (increased 
appetite) and polydipsia (increased thirst and consequent elevated 
water intake) by the supplementation of O. japonicus extracts, 
and body weight loss was decreased significantly (P < 0.05). 
Body weights in the groups treated with the O. japonicus ethanol 
extract (DBE1 and DBE2 groups) increased about 8-9%, while 
in the DBC group body weight was reduced by about 13.2% 
at the end of experimental period compared to initial body 
weight. The ethanol extract was more effective than the water 
extract in alleviating diabetic symptoms, similar to the results 
reported by Kang et al. [33]. FBG levels in the DBC group during 
the 4 weeks were in the range of 325.4-331.3 mg/dL (Fig. 1). 
However, the FBG levels of the diabetic rats were significantly 
decreased by supplementation of O. japonicus extract compared 
to the DBC group, suggesting that the mode of anti-diabetic 
activity by flavonoids is possibly related to hypoglycemic action. 306 Antidiabetic effect of Orostachys japonicus
Flavonoids, with a C-3 position, have inhibitory action against 
aldose reductase [34], which can be considered hypoglycemic 
action [35]. This activity may be increased based on their ability 
to establish an H bound between the compound and its target. 
It was also reported that the basic flavone structure of flavonoids 
possesses anti-diabetic activity [30].
The STZ-induced diabetic rats exhibited obvious abnormalities 
of lipid metabolism as evidenced from significant elevations of 
serum TC, TG, and LDL-C as well as AI and CRF values, and 
reduced HDL-C levels. Supplementation of the O. japonicus 
extracts for 4 weeks to the diabetic rats caused hypolipidemic 
action through significant depression of TG levels in the serum 
and organ tissues of the groups treated with the ethanol extract 
compared to the water extract, suggesting that the ethanol extract 
would be effective against cardiovascular disease and/or atherosclerosis, 
and perhaps control dyslipidemia in diabetes. These results are 
similar to previous reports depicting flavonoids as potential 
hypolipidemic agents, because the lowering effects of flavonoids 
on TG and LDL-C levels were greater than the effect on TC 
level in diabetic rats [3,30,36].
  Therefore, the reduction of serum 
TG following treatment with O. japonicus might also facilitate 
glucose oxidation and utilization, and subsequently lead to the 
reduction of hyperglycemia. The increased gluconeogenesis and 
ketogenesis in diabetes might be due to elevated transaminase 
activity such as by GOT and GPT [37]. Abnormal serum GOT 
and GPT activities indicate tissue damage by toxicants or disease 
and are of clinical and toxicological importance [38]. Treatment 
with O. japonicus for 4 weeks reduced these enzyme activities 
compared to the non-treated DBC group. We expect that continuous 
supplementation of O. japonicus extracts may result in recovery 
of impaired hepatic function. 
In the DBW2 and DBE2 groups treated with the water and 
ethanol extracts at 0.5%, the decline in hepatic TG was better 
than that of TC in the DBC group (Table 5). The ethyl acetate 
fraction from O. japonicus decreased serum and hepatic TG 
levels about 45.7% and 32.4%, respectively, in comparison to 
the diabetic control group. These results suggest that this fraction 
from O. japonicus contains certain sterols and flavonoids such 
as kaempferol, astragalin, and isoquercitrin, and administration 
of this fraction is associated with reduced plasma clotting times 
[36]. 
A decline status of hepatic glycogen content has frequently 
been observed in diabetes [39].
  Higher glucose levels and lower 
hepatic glycogen content could be attributed to less availability 
of the active form of glycogen synthetase [36]. Especially, since 
STZ causes selective destruction of β-cells of the pancreas, it 
could be predicted that glycogen levels in liver and muscle tissues 
decrease as glucose influx into the liver is inhibited in the absence 
of insulin. Our study shows that glycogen levels in the groups 
treated with the O. japonicus ethanol extract were recovered to 
the levels of normal rats (Table 6). This indicates that one of 
the bioactivities of O. japonicus might be the management of 
hepatic glycogenesis, and quercetin could potentially have hypog-
lycemic activity [19].
Many studies have reported significantly increased lipid 
peroxide contents in the liver and kidney tissues of diabetic rats 
[40,41]. In STZ-induced diabetic animals, powerful free radical 
oxidants by STZ result in increased serum lipid peroxide content 
due to the oxidation of cells [42]. The lower content of lipid 
peroxide by supplementation of O. japonicus extract may be 
closely connected to its polyphenol and flavonoid content [17], 
expecting that these components decrease lipid peroxide content 
in tissues [43]. The hepatic antioxidant activity of the ethanol 
extract of O. japonicus was more efficient than that of the water 
extract. 
Overall, we found that O. japonicus extract has multiple blood 
glucose lowering and hypolipidemic effects, and had hypothesized 
that it would increase antioxidative system activity in vivo the 
as same as it does in vitro. Further systematical anti-diabetic 
studies should be performed to elucidate the exact mechanism(s) 
and to develop O. japonicus as a potential material for 
anti-diabetic activity.
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